Open AccessImplementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
Author(s) -
Zishan K. Siddiqui,
Mihir Chaudhary,
Matthew L. Robinson,
Anna B McCall,
Ria Peralta,
Rogette Esteve,
Charles W. Callahan,
Yukari C. Manabe,
James D. Campbell,
J. Kristie Johnson,
Maryam Elhabashy,
Melinda E. Kantsiper,
James R. Ficke
Publication year - 2021
Publication title -
microbiology spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.502
H-Index - 51
ISSN - 2165-0497
DOI - 10.1128/spectrum.01008-21
Subject(s) - asymptomatic , medicine , confidence interval , covid-19 , asymptomatic carrier , disease , infectious disease (medical specialty)
The BinaxNOW rapid antigen COVID-19 test had a sensitivity of 87% in symptomatic and 71% asymptomatic individuals when performed by health care workers in a high-throughput setting. The performance may expedite isolation decisions or referrals for time-sensitive monoclonal antibody treatment in communities where timely COVID PCR tests are unavailable.